Friday, October 3, 2014

Top US Stocks To Invest In Right Now

Top US Stocks To Invest In Right Now: Johnson & Johnson(JNJ)

Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment provides products used in baby care, skin care, oral care, wound care, and women?s health care fields, as well as nutritional, over-the-counter pharmaceutical products, and wellness and prevention platforms under the brands of JOHNSON?S, AVEENO, CLEAN & CLEAR, JOHNSON?S Adult, NEUTROGENA, RoC, LUBRIDERM, DABAO, LISTERINE, REACH, BAND-AID, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC. The Pharmaceutical segment offers products in various therapeutic areas, such as anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, and virology. Its principal products include REMICADE for the treatment of immune me diated inflammatory diseases; STELARA for the treatment of moderate to severe plaque psoriasis; SIMPONI, a treatment for adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis; VELCADE for the treatment of multiple myeloma; PREZISTA and INTELENCE for treating HIV/AIDS patients; NUCYNTA for moderate to severe acute pain; INVEGA SUSTENNAtm for the acute and maintenance treatment of schizophrenia in adults; RISPERDAL CONSTA for the management of bipolar I disorder and schizophrenia; and PROCRIT to stimulate red blood cell production. The Medical Devices and Diagnostics segment primarily offers circulatory disease management products; orthopaedic joint reconstruction, spinal care, and sports medicine products; surgical care, aesthetics, and women?s health products; blood glucose monitoring and insulin delivery products; professional diagnostic products; and disposable contact lenses. The company was founded in 1886 a! nd is based in N e w Brunswick, New Jersey.

Advisors' Opinion:
  • [By Dan Carroll]

    The success comes as the rheumatoid arthritis market heats up. Some of the leading treatments for the disease include best-selling immunology drugs such as AbbVie's (NYSE: ABBV  ) Humira and Johnson & Johnson's (NYSE: JNJ  ) Remicade, each of which made more than $6 billion for their companies last year.

  • [By Keith Speights]

    Has anyone noticed a common theme among the first-quarter results for many of the big medical-device companies? In case you missed earnings announcements from Abbott Labs (NYSE: ABT  ) , Boston Scientific (NYSE: BSX  ) , Edwards Lifesciences (NYSE: EW  ) , Johnson & Johnson (NYSE: JNJ  ) , or Stryker (NYSE: SYK  ) , the following chart shows how their medical-device business fared during the quarter.

  • source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-us-stocks-to-invest-in-right-now.html

No comments:

Post a Comment